To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Entelev, also known as Cancell and Cantron, is a liquid mixture that was promoted by its creator to be an effective treatment for cancer. The National Cancer Institute (NCI) tested the ingredients of the mixture against cancer cells and found no conclusive results. Although a double blind study has never been conducted on Entelev, many cancer patients claimed to have had remarkable recoveries after undergoing treatment with it. It was initially given out for free, as it was not legally marketable as a drug, until the FDA shut down Sheridan's operation. Over the years, at least two other products with the same formula have been created and marketed [supposedly] at just over production cost.
Additional recommended knowledge
About Entelev's Creation
Entelev is the original formula of James V. Sheridan, a chemist and researcher from Michigan. He developed the concept for his formulation in 1936, commenced animal studies in the late 40's, attempted to undergo clinical trials in the 50's while working for the Michigan Cancer Institute, and in the early 60's, he conducted further research while working with Battelle Laboratories (the testing center for the National Cancer Institute). Between 1974 and 1983 Mr. Sheridan gave the formula away free of charge to over one thousand people.
The US Food and Drug Administration (FDA) has listed the ingredients of Cancell/Entelev as the chemicals inositol, nitric acid, sodium sulfite, potassium hydroxide, sulfuric acid, and catechol. None of these have been shown to be effective in the treatment of cancer.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Entelev". A list of authors is available in Wikipedia.|